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Increased Expression of Wnt2 and SFRP4 in Tsk
Mouse Skin: Role of Wnt Signaling in Altered Dermal
Fibrillin Deposition and Systemic Sclerosis
Julie Bayle1, Jennifer Fitch2, Kimberly Jacobsen2, Rajiv Kumar3, Robert Lafyatis1 and Raphae¨l Lemaire1
Systemic sclerosis (SSc) is a complex human disorder characterized by progressive skin fibrosis. To better
understand the molecular basis of dermal fibrosis in SSc, we analyzed microarray gene expression in skin of the
Tight-skin (Tsk) mouse, an animal model where skin fibrosis is caused by an in-frame duplication in fibrillin-1
(Fbn-1). Tsk skin showed increased mRNA levels of several genes involved in Wnt signaling, including Wnt2,
Wnt9a, Wnt10b and Wnt11; Dapper homolog antagonist of b-catenin (DACT1) and DACT2; Wnt-induced
secreted protein 2; and secreted frizzled-related protein (SFRP)2 and SFRP4. RNase protection and northern blot
confirmed microarray results. Furthermore, Wnt3a markedly stimulated matrix assembly of microfibrillar
proteins, including Fbn-1, by cultured fibroblasts, suggesting that Wnts contribute to increased microfibrillar
matrices in Tsk skin. Further analysis showed that SFRP4 expression is specifically increased in tissues
expressing Tsk-Fbn-1, such as skeletal muscle and skin. The increase in SFRP4 mRNA in Tsk skin started 2 weeks
after birth, following the increase in Wnt2 mRNA that occurred at birth. This suggests that SFRP4 may modulate
Wnt functions in Tsk skin fibrosis. Lesional skin from SSc patients also showed large increases in SFRP4 mRNA
and protein levels in the deep dermis compared to healthy skin, suggesting that the Wnt pathway might
regulate skin fibrosis in SSc.
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INTRODUCTION
Systemic sclerosis (SSc) or scleroderma is a chronic hetero-
geneous connective tissue disease featuring cutaneous and
visceral fibrosis, autoimmunity, and vascular injury (Varga
and Abraham, 2007). Skin fibrosis results from excessive
deposition of extracellular matrix proteins, especially type I
collagen, but its pathogenesis remains unclear (Fleischmajer
et al., 1983; Kissin and Korn, 2003; Denton et al., 2006).
Animal models for SSc such as the Tight-skin (Tsk) mouse
(Green et al., 1976; Kasturi et al., 1994), as well as genetic
studies, have shown an association between fibrosis and
fibrillin (Fbn-1) mutations. The phenotype of the Tsk mouse is
caused by a large in-frame duplication of exons 17–40 of Fbn-1
and models certain dermal features of SSc (Siracusa et al.,
1996; Saito et al., 1999; Pablos et al., 2004). Fbn-1 is the
major structural protein of connective tissue microfibrils,
which are key components of elastic fibers. In addition to
phenotypic similarities to SSc, such as increased skin
thickness and tethering, Tsk mice also show certain
pathologic similarities to SSc in upregulated expression of
microfibrillar proteins Fbn-1, fibulin-2, and microfibril-
associated glycoprotein-2 (MAGP-2) (Fleischmajer et al.,
1983; Lemaire et al., 2004a, b, 2005, 2007). These similari-
ties suggest that a more complete understanding of the
pathophysiology of Tsk mouse may provide an insight
into matrix biology relevant to SSc. In addition, the Tsk
model offers a special opportunity to examine how a
well-defined alteration in a matrix protein, Fbn-1, is
communicated to cells in the matrix and leads to skin fibrosis
and associated widespread changes in matrix composition
(Lemaire et al., 2006).
Over the last years, several groups have used microarray
analyses to obtain RNA expression profiles of skin from SSc
patients (Zhou et al., 2001; Whitfield et al., 2003; Gardner
et al., 2006). Among regulated genes, downregulation of Wnt
inhibitory factor, as well as upregulation of secreted frizzled-
related protein 4 (SFRP4) was detected in SSc. However,
Wnt-related signaling has not been investigated previously in
SSc or Tsk mice. Although the potential role of Wnt signaling
in dermal matrix regulation is unclear, distinctive Wnt
members have been shown to regulate the hierarchical
morphogenesis of skin regions in embryonic chicken (Chang
et al., 2004). The early changes of skin tethering in Tsk mice,
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which can be appreciated shortly after birth, suggest that
matrix dysregulation in Tsk might represent developmental
dysregulation. Although the role of Wnts in skin fibrosis is
unknown, SFRP4, a member of the SFRPs shown to inhibit
Wnt signaling, has previously been implicated in kidney
fibrosis (Surendran et al., 2005).
Multiple proteins are involved in the complex regulation
of Wnt-mediated developmental processes (Clevers, 2006;
Gordon and Nusse, 2006; Kikuchi et al., 2006). The
transduction of Wnt signals toward transcription activation
of targets genes is initiated by binding of extracellular Wnt
ligands to Frizzled seven-pass transmembrane receptors.
After receptor activation, intracellular signals are transduced
through the canonical Wnt/b-catenin and non-canonical
pathways. Intracellular Dapper homolog antagonist of
b-catenin (DACT) proteins have been shown to inhibit both
Dishvelled (Dvl)-mediated canonical and non-canonical Wnt
pathways. Other proteins that might be important in down-
stream signaling by Wnts include the Wnt-induced secreted
proteins (WISP), named WISP-1/CCN4, WISP-2/CCN5, and
WISP-3/CCN6, also members of the CCN family of growth
factors.
SFRPs are a five-member family of extracellular proteins
that were first identified as Wnt signaling repressors that
interact with both Wnt ligands and their Frizzled receptors
(Finch et al., 1997; Melkonyan et al., 1997; Uren et al.,
2000). SFRPs also bind to proteins structurally unrelated to
Wnts (Hausler et al., 2004; Lee et al., 2004). SFRPs are
secreted Wnt inhibitors that contain an N-terminal region
homologous to the extracellular cysteine-rich domain of the
Frizzled family proteins but lack the transmembrane and
intracellular regions required for anchoring to the plasma
membrane and signaling transduction, respectively (Rattner
et al., 1997; Jones and Jomary, 2002).
In this study, we have identified by microarray analysis a
comprehensive list of genes overexpressed in Tsk mouse skin.
The most highly increased genes fall into four main groups:
microfibrill-associated genes, collagen genes, Wnt-signaling
pathway genes, and other developmental regulator genes,
including bone morphogenetic proteins (BMPs) and CCNs.
Here we show that several genes of theWnt pathway are highly
increased in Tsk skin, including Wnt2, Wnt9a, Wnt10b,
Wnt11, DACT1, DACT2, WISP2, and SFRP4. Wnt is shown
to increase Fbn matrix formation in vitro, a key pathogenic
feature in Tsk hypodermis. Further, we show that SFRP4 is
highly upregulated in skin from Tsk mice and from SSc patients.
Together, these data suggest that Wnt stimulation plays an
important role in matrix remodeling in Tsk mice and supports
potential related roles in dermal fibrosis in SSc patients.
RESULTS
Wnt signaling is increased in Tsk mice skin
To better understand the molecular mechanisms of skin
fibrosis in Tsk mice, we analyzed gene expression in the skin
of 6-week-old wild-type (WT) and Tsk mice using Affymetrix
Genechips arrays. Genes with the highest upregulation in Tsk
skin were microfibrillar genes, collagen genes, Wnt signaling
pathway genes, and other developmental regulators BMPs
and CCNs (Table 1). Increases in microfibrillar MAGP-2
(MFAP5), Fbn-1, and fibulin-2 confirmed our previously
published data (Lemaire et al., 2004a, b, 2005). Several Wnt
genes and genes involved in mediating or antagonizing Wnt
signals were highly upregulated, including Wnt2, Wnt9a,
Wnt11, DACT1/DACT2, WISP2, and SFRP2/SFRP4. RNase
protection assay targeting Wnt mRNAs confirmed the
microarray data (Figure 1). Wnt2 was most highly upregu-
lated (4.07-fold increase in Tsk compared to WT skin).
Although Wnt9a was not detected, Wnt3a, Wnt10b, and
Wnt11 were also modestly increased in Tsk skin (1.3-, 1.4-,
and 1.9-folds, respectively).
SFRP4 expression is increased in Tsk mouse skin
In addition to upregulated Wnt expression, the Tsk micro-
array data showed highly upregulated SFRP2 and SFRP4
mRNAs in Tsk skin. To validate our microarray results, we
analyzed SFRP4 RNA and protein in skin of matching pairs of
8-week-old Tsk and control mice using northern blot and
western blot. SFRP4 mRNA was markedly increased in Tsk
skin compared to WT mice skin (6.2-fold; Figure 2a). This
was confirmed by real-time PCR analysis (data not shown).
Expression of SFRP4 was similarly increased at the protein
level in skin of Tsk mice compared to control mice (4.0-fold;
Figure 2b). Upregulation of Wnt2, WISP2, DACT1, and
SFRP2 genes was also confirmed by northern blot analysis
(Figure 3 and data not shown).
Wnt2, SFRP4, and Tsk Fbn-1 mRNA expressions are coregulated
in tissues from Tsk mice
To better understand the relationship between increased
Wnt2, SFRP4, and Tsk-Fbn-1, we looked at the expression of
these genes in various adult tissues by northern blot. Skin,
skeletal muscle, and heart tissues, and to a lesser degree
kidney tissue, from Tsk mice showed high upregulation of
Fbn-1 and Tsk-Fbn-1 mRNAs compared to Fbn-1 mRNA in
WT mice (Figure 3a). Notably, Wnt2 and SFRP4 expression
mostly followed expression of Fbn-1 and Tsk-Fbn-1, as Wnt2
and SFRP4 mRNAs were highly upregulated in Tsk skeletal
muscle and skin. Heart and kidney tissues showed lower
levels of SFRP4 and detectable Fbn-1, whereas expressions of
Fbn-1 and SFRP4 were undetectable in the brain, spleen, and
liver (Figure 3a and b). These data suggested that Wnt2 and
SFRP4 contribute to the effects of Tsk-Fbn on matrix
remodeling.
The onset of increased SFRP4 mRNA in Tsk skin is post-natal
and follows increased Wnt2 mRNA
To better understand how Wnts might developmentally
regulate the matrix abnormalities in Tsk skin, we analyzed
Wnt2 and SFRP4 mRNA in skin of mice of different ages by
northern blot. Tsk mice showed both WT and Tsk-Fbn-1
mRNA transcript expression from the earliest age analyzed
(embryo stage E18.5) that continued at a lower level in
weaned mice (4 weeks). WT mice showed only the WT Fbn-1
transcript in the same pattern (Figure 4a, first panel).
Importantly, increased expression of SFRP4 mRNA was not
detected until 2 weeks after birth in Tsk skin, increasing
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further over time (Figures 2a, 4a and b). Unlike SFRP4, Wnt2
showed upregulation as soon as birth (Figure 4c and d),
suggesting that Wnt2 might function before SFRP4 in altering
the phenotype of Tsk mice.
Wnt stimulates Fbn matrix assembly
We have previously described that Tsk mice show marked
increases in hypodermal Fbn matrix (Lemaire et al., 2004b).
To determine whether the Wnt pathway might mediate
matrix remodeling in Tsk skin, we looked at its effect on Fbn
matrix in vitro. Based on commercial availability and
activation of the canonical b-catenin pathway, this investi-
gation was carried out using Wnt3a. Treatment of mouse
embryonic fibroblasts (MEF) by Wnt3a increased by more
than threefold the level of Fbn-1 deposited within the
extracellular matrix, while not affecting the non-microfibrillar
protein fibronectin (Figure 5a). As Wnt3a treatment did not
change the levels of Fbn-1 mRNA (Figure 5b, left panel) and
Fbn-1 protein in the medium (Figure 5b, right panel),
this result suggests that Wnt3a regulates matrix assembly of
Fbn-1. Increased levels of Fbn-1 deposited in the matrix after
treatment with Wnt3a were also seen in culture of primary
skin fibroblasts isolated from normal and SSc patients (Figure
5c). Wnt3a also markedly stimulated matrix deposition of
other microfibrillar proteins, including MAGP-2 and elastin
(Figure 5d), similar to transforming growth factor-b (TGF-b)
(Kissin et al., 2002; Lemaire et al., 2005, 2007). However,
Wnt3a treatment of MEFs did not induce phosphorylation of
Smad3, unlike TGF-b (Figure 5e), suggesting that Wnt3a
stimulates matrix assembly of Fbn-1 independently of
activation of the canonical Smad-dependent TGF-b pathway.
SFRP4 mRNA expression is increased in the skin of SSc patients
A review of microarray data from Whitfield et al. (2003),
Gardner et al. (2006), and our unpublished observations from
skin of patients with SSc showed strikingly increased SFRP4
expression compared to control skin. To determine whether
SFRP4 expression was altered in SSc, we analyzed SFRP4
mRNA in lesional and non-lesional skin from 12 SSc patients
and four healthy control subjects by quantitative real-time
PCR (Table 2). SFRP4 mRNA was detected at a low level in
healthy skin and was significantly increased in lesional skin
of SSc patients (Figure 6, 7.2-fold increase). A more moderate
but significant increase of SFRP4 mRNA was also detected in
non-lesional skin of the same SSc patients compared to
healthy subjects (Figure 6, 3.7-fold increase).
Table 1. Upregulated genes in Tsk mouse skin, as identified by DNA arrays analysis1
Gene symbol Gene name WT mean Tsk mean Tsk/WT ratio
Microfibril-associated genes
MFAP5 Microfibrillar associated protein 5 718 6,405 8.9
FBN1 Fibrillin-1 2,988 19,253 6.4
EMILIN 2 Elastin microfibril interfacer 2 1,508 6,278 4.2
FBLN2 Fibulin 2 1,741 4,822 2.8
Collagen genes
COL14A1 Procollagen, type XIV, alpha 1 1,944 11,058 5.7
COL8A1 Procollagen, type VIII, alpha 1 307 1,419 4.6
COL12A1 Procollagen, type XII, alpha 1 269 1,007 3.7
Wnt-signaling genes
DACT2 Dapper homolog 2, antagonist of beta-catenin 72 583 8.1
WNT2 Wingless-related MMTV integration site 2 181 1,214 6.7
WISP2 Wnt1 inducible signaling pathway protein 2 379 1,875 5.0
DACT1 Dapper homolog 1, antagonist of beta-catenin 762 3,403 4.5
SFRP4 Secreted frizzled-related sequence protein 4 1,352 6,008 4.4
WNT9A Wingless-related MMTV integration site 9a 185 608 3.3
SFRP2 Secreted frizzled-related sequence protein 2 1,478 4,549 3.1
WNT11 Wingless-related MMTV integration site 11 181 425 2.4
Other developmental regulator genes
NOV Nephroblastoma overexpressed gene 222 5,151 23.2
BMP8A Bone morphogenetic protein 8a 25 208 8.3
BMP6 Bone morphogenetic protein 6 166 687 4.2
1Genes shown on this list were selected on the basis ofX2.0-fold increase and mean values over 200 in Tsk skin. Genes clustered in four main families as:
microfibril-associated genes, collagen genes, Wnt-signaling genes and other developmental genes. Expression data were normalized to global signal.
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Levels of SFRP4 protein are increased in the deep dermis of
lesional SSc skin
To determine whether and where increased expression of
SFRP4 protein was present in vivo, lesional skin from 19
patients with SSc and 12 healthy controls was analyzed with
a rabbit polyclonal anti-SFRP4 antibody by immunohisto-
chemistry. Consistent with reverse transcription-PCR data,
SFRP4 protein was increased in SSc skin compared to healthy
skin (Figure 7a and c vs b and d). SFRP4 staining was
significantly increased in and around cells within the
papillary dermis (Figure 7a vs b; 1.6-fold average) and the
deep reticular dermis (Figure 7c vs d; 4.3-fold average)
compared to healthy skin that showed only low SRFP4
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Figure 1. Wnt mRNA expression is increased in Tsk mouse skin.
(a) Representative autoradiographic images of RNase protection assays
performed from skin RNA from Tsk and WT mice. Arrows point to specific
mRNA of the Wnt family. (b) Graphic representation of mean relative changes
in Wnt mRNA levels upon expression of Tsk-Fbn-1. Wnt levels were
measured by direct b-counting and normalized to L32 expression. Data are
the average of three independent experiments on 2-month-old Tsk and WT
mouse littermates. Values represent the fold-increase in gene expression.
Some Wnt genes may have two designations: Wnt2/Wnt2a, Wnt10b/Wnt12,
Wnt13/Wnt2b. ND¼ not determined (expression level was low or absent).
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Figure 2. Overexpression of SFRP4 mRNA and protein in skin of Tsk mice.
(a) Increased SFRP4 mRNA in skin of Tsk mice compared to control mice
(WT). RNA was analyzed for SFRP4 and Fbn-1 by northern blot, quantified
using phosphorimaging, and normalized to 18S ribosomal RNA. Data shown
are representative of three independent experiments performed on matching
pairs of 8-week-old Tsk and control mice. (b) Increased SFRP4 protein in Tsk
mouse skin compared to control mouse (WT). Western blot analyses were
performed using total lysate of skin from WT and Tsk mice (left panel).
Expression of the 55 kDa SFRP4 protein was normalized against
Ponceau-stained total proteins. Protein levels were quantified by densitometry
analysis. Data shown are representative of three independent experiments
performed on three matching pairs of mice. Values and bars represent mean
and standard error (7SEM) *Po0.05, Student’s unpaired t-test, Tsk versus WT.
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Figure 3. Expression of Wnt2 and SFRP4 mRNA in various tissues of Tsk
and WT mice. Total RNA was isolated from different tissues (brain, spleen,
skeletal muscle, heart, skin, kidney, and liver) of 12-week-old WT and Tsk
mice and analyzed for (a) SFRP4 and Fbn-1 or (b) Wnt2 by northern blot.
Two SFRP4 transcripts at 1.9 and 4.2 kb were detected. Results are
representative of two independent experiments.
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protein level (Figure 7e). SFRP4 staining was observed at
similar levels around blood vessels and in the epidermal layer
of both healthy and SSc skin.
DISCUSSION
The molecular mechanisms underlying skin fibrosis in SSc
and in Tsk mice remain poorly understood. In this study, we
describe the overexpression of several Wnt signaling mole-
cules in the skin of Tsk mice and extend these observations to
human SSc. We find that Wnt signaling is affected in Tsk skin
at several levels. Several Wnt genes, including Wnt2a,
Wnt9a, Wnt10b, and Wnt11, are highly upregulated, as well
as mediators and regulators of Wnt signaling, including
intracellular molecules such as DACT1/2 and WISP2, and
extracellular molecules such as SFRP2 and SFRP4. Finally,
Wnt signaling increased Fbn fibrillinogenesis in vitro, a key
aspect of skin fibrosis in Tsk mice. Despite reports of
decreased stability of Fbn matrix produced by SSc fibroblasts
in vitro (Wallis et al., 2001), Fbn matrix is increased in the
dermis of SSc skin (Fleischmajer et al., 1991). Thus, our
results suggest that Wnt signaling might contribute to
upregulated Fbn matrix in Tsk and SSc skin.
How the Tsk-Fbn-1 mutation induces altered hypodermal
matrix and skin tethering is unknown. Our study suggests that
skin fibrosis and matrix remodeling may be mediated in Tsk
mice by developmental regulators, in particular Wnts.
Importantly, we show that Wnt expression is increased in
skin and other Fbn-containing tissues in Tsk mice during late
development, at times before the phenotype of these animals
is readily detectable. These data strongly suggest that the Tsk-
Fbn-1 mutation affects late developmental processes at
around the time that Fbn-1 protein can first be detected
(Quondamatteo et al., 2002). The mechanism behind altered
expression of the Wnt family is unclear. However, we show
that treatment of fibroblasts by Wnt3a markedly stimulates
deposition of Fbn-1. As Fbn-1 is dramatically increased in the
hypodermal layer of Tsk mice, these results suggest that Wnt
upregulation may play a direct role in the altered matrix in
Tsk mice. The importance of Wnt signaling in skin remodel-
ing in Tsk is consistent with the function of Wnts in skin
morphogenesis in embryonic chicken (Chang et al., 2004).
Indeed, involvement of Wnt signaling has been observed in
various sites of epithelial–mesenchymal interaction (Maretto
et al., 2003) and it is considered to be critical for the
establishment of hair follicles during embryonic development
(Reddy et al., 2001; Andl et al., 2002). Our results suggest
that the Wnts may also play an important function in
regulating hypodermal development, such that alterations in
Fbn, one of the most abundant proteins in the hypodermis,
are in some manner transmitted to the developing mesenchy-
mal cells to alter Wnt expression and matrix composition.
Our study shows a large increase in SFRP4 in the skin of
Tsk mice. SFRP4, also known as DDC-4/rFrp rat homolog
(Wolf et al., 1997), human FrpHE (Abu-Jawdeh et al., 1999),
or FrzB-2 Xenopus homolog, is a secreted glycoprotein
previously reported as expressed in various tissues (Rattner
et al., 1997; Leimeister et al., 1998; James et al., 2000;
Schumann et al., 2000; Tebar et al., 2001; Yam et al., 2005).
We show that SFRP4 mRNA expression was detectable in
only select normal tissues from adult mice, and that its
expression markedly increased in Tsk skin and skeletal
muscle. The pattern of expression is consistent with
pathological examination of Tsk muscle, which shows a
large increase in connective tissues surrounding the muscle
(unpublished observation), suggesting that SFRP4 expression
and other genes in Tsk mouse are selectively increased in
Fbn-rich hypodermal connective tissue and facia between the
skin and skeletal muscle.
Although the functions of SFRPs are incompletely
understood, they are best characterized as repressors of
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Figure 4. Increase of SFRP4 mRNA in Tsk skin is late in development and
follows increased Wnt2. RNAs from control, WT, or Tsk skin were extracted
at E18.5 embryo stage and at 0, 1, 2, and 4 weeks after birth and analyzed
for (a) Fbn-1 and SFRP4 or (c) Wnt2 by northern blot. mRNA levels were
quantified by phosphorimaging and normalized to 18S rRNA. Values
and error bars shown in (b) and (d) represent mean and standard error
(7SEM). Data shown are representative of two (b) and three (d) independent
experiments.
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Wnts. SFRPs contain an extracellular domain homologous to
Wnt receptors, Frizzled, that prevent binding to and
activation of Frizzled by Wnts (Wang et al., 1997). SFRP4
has been shown to bind to Wnt8 in a Xenopus model (Abu-
Jawdeh et al., 1999). Several groups have demonstrated the
repressive function of SFRP4 on Wnt signaling (Horvath et al.,
2004; Suzuki et al., 2004). A recent in vivo study demon-
strated that rats infused with SFRP4 recombinant protein have
reduced amounts of renal b-catenin protein, increased
phosphorylated b-catenin signaling, and reduced kidney
fibrosis (Surendran et al., 2005). Together, these data suggest
that increased SFRP4 in Tsk skin may represent a counter-
regulatory mechanism of Wnt activity. This is consistent with
the late increase in SFRP4 levels in Tsk skin following an
earlier increase in Wnt2 levels. We extended our observa-
tions in Tsk skin to human SSc and showed significantly
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increased expression of SFRP4 mRNA and protein in lesional
and non-lesional skin from SSc patients. Thus, SFRP4 may
play a similar role in SSc and represent a marker of fibrosis in
SSc skin.
Our results highlight the possibility that fibrosis in SSc may
be regulated by several different cytokines (Denton et al.,
2006). Previous studies have indicated important roles for
cytokines in the development of fibrosis in SSc, in particular
TGF-b (Chen et al., 2006), and connective tissue growth
factor (CTGF/CCN2) (Igarashi et al., 1995; Shi-wen et al.,
2000; Leask et al., 2002). Two groups have recently identified
a large set of genes that are upregulated in SSc skin, some of
Table 2. Clinical data from patients with SSc and control healthy subjects1
Subject
Age
(years)/sex Ethnicity
Duration
(months) Skin score Therapy
SSc 12,3 44/F Caucasian 17 13 None
SSc 22,3 34/F Caucasian 20 16 None
SSc 32,3 51/F Caucasian 18 25 MTX
SSc 42,3 48/M Caucasian 19 9 Rituximab
SSc 52,3 55/F Caucasian 20 37 None
SSc 62,3 37/M Caucasian 12 24 None
SSc 72,3 34/F Asian 18 15 None
SSc 82,3 57/F Caucasian 8 17 None
SSc 92,3 44/F Caucasian 7 9 None
SSc 102,3 45/F Caucasian 8 16 None
SSc 112,3 67/F Caucasian 10 37 MTX
SSc 122,3 55/M African-American 35 17 CYC
SSc 133 39/F Caucasian 48 28 None
SSc 143 32/F Caucasian 96 15 MTX
SSc 153 65/F Caucasian 5 31 None
SSc 163 69/F Caucasian 6 21 None
SSc 173 36/F Caucasian 13 18 None
SSc 183 44/M Caucasian 6 34 None
SSc 193 33/M Caucasian 18 15 None
Control 12 44/F African-American
Control 22 34/F African-American
Control 32 40/F Caucasian
Control 42,3 34/M Hispanic
Control 53 46/F Caucasian
Control 63 51/F African-American
Control 73 41/M Caucasian
Control 83 41/F African-American
Control 93 74/F African-American
Control 103 36/M Caucasian
Control 113 43/F Caucasian
Control 123 30/M Caucasian
Control 133 56/M Caucasian
Control 143 40/F Caucasian
Control 153 50/F Caucasian
CYC, cyclophosphamide; F, female; M, male; MTX, methotrexate.
1Duration of disease from first non-Raynaud’s symptom; modified Rodnan skin scores on a 51-point scale and 17 body sites, and medication taken by each
patient are indicated.
2Analyzed by real-time PCR.
3Analyzed by immunohistochemistry.
www.jidonline.org 877
J Bayle et al.
Wnt Signaling in Skin Fibrosis
which are known to be induced by TGF-b (Whitfield
et al., 2003; Gardner et al., 2006). These microarray
studies also showed dysregulation of several molecules
in the Wnt pathway, including downregulation of Wnt
inhibitory factor as well as upregulation of SFRP4. Although
the role of increased SFRP4 expression in SSc remains
unclear, its effect might be to antagonize upregulated Wnt
expression in affected tissues. As shown in the Tsk mouse,
such regulation might have important effects on matrix
composition.
In conclusion, this report provides new evidence for a
potential role of Wnts and Wnt antagonists in regulating
dermal matrix composition in SSc and Tsk mice. Further
understanding of the role of Wnts and Wnt antagonists in Tsk
mice should provide an insight into matrix regulation during
development and pathologic fibrosis.
MATERIALS AND METHODS
Patients and controls
All patients with SSc had diffuse cutaneous disease, according to the
American College of Rheumatology criteria for SSc. Controls had no
history of skin disease. Punch biopsies were obtained from the dorsal
mid-forearm, an area of skin that was affected in all of the patients
with SSc. Biopsies were performed after patient written consent and
with approval of the Institutional Review Board for Human Studies at
Boston University Medical Center. The study was conducted
according to the Declaration of Helsinki Principles.
Animals
C57BL/6-Fbn-1Tskþ /þ Pldnpa mice (Tsk/þ ) were obtained from the
Jackson Laboratory (Bar Harbor, ME), and produced by breeding of
Tsk/þ with C57BL/6 mice according to an approved Institutional
Animal Care and Use Committee protocol. Tsk mice were identified
by manual assessment of skin tightness over the back and genotyping
by PCR amplification on tail genomic DNA using the following
Fbn-1 primers: 50-CCAGACTACATGCAAGTGAACGG-30 and
50-CCTTTCCTGGTAACATAGGAAAGC-30.
Cell culture
MEFs, MEF-TE cells overexpressing tropoelastin-enhanced
green fluorescent protein and conditionally overexpressing mouse
MAGP-2 (Lemaire et al., 2005; Lemaire et al., 2007), and
human dermal fibroblasts from normal volunteers or patients with
SSc obtained as previously described (Kissin et al., 2002) were
grown in 10% fetal bovine serum-supplemented DMEM (Gibco,
Carlsbad, CA) at 371C in a humidified 8% CO2 incubator. Cells
were cultured in the presence or absence of 100 ng/ml Wnt3a
(R&D Systems, Minneapolis, MN).
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Total RNA extraction
Total RNA from mice tissues was prepared by disruption directly in
Trizol reagent (Invitrogen Life Technologies, Rockville, MD), using a
Polytron homogenizer (Brinkman, Westbury, NY). After centrifuga-
tion for 10minutes at 4,000 g, total RNA was purified, according
to the manufacturer’s protocol. Fresh human skin biopsies (1–3mm)
were put in RNA later (Qiagen, Carlsbad, CA), and stored at 201C
until processed. Tissues were transferred into RLT buffer (Qiagen),
where they were thinly minced with scissors before being disrupted
using a Polytron homogenizer. RNAs were purified from RLT buffer
supernatant using the RNeasy total RNA kit, according to the
manufacturer’s protocol (Qiagen, Valencia, CA). RNA was extracted
from fibroblasts using the RNeasy total RNA kit.
Gene profiling
To analyze gene expression in skin of Tsk and WT mice, cDNA
synthesized from RNA purified from skin biopsies of the back of 6-
week-old littermate mice was hybridized to mouse microarray
containing 39,000 mouse-gene transcripts (GeneChips mouse
genome 430.2.0, Affymetrix, Santa Clara, CA) and developed
according to the Amplification for Eukaryotic Targets protocol
(Affymetrix). The Boston University Microarray Facility performed
these analyses as described previously (York et al., 2007).
RNase protection assay
Validation of individual Wnt gene expression was performed using
two custom multi-probe template sets to quantitatively determine
expression of Wnt 1, 2, 3a, 3b, 4, 5b, and 6 (set mWnt-1 no. 550925;
Pharmingen Corp., San Jose, CA), and 7a, 7b, 8d, 10a, 10b, 11, 13,
and 15 (set mWnt-2 no. 550249; Pharmingen Corp.). Single-stranded
32P-labeled cRNA probes were hybridized to purified RNA, digested,
and analyzed by denaturing polyacrylamide gel electrophoresis, as
described previously (Cho et al., 2002). All gene expression was
normalized to the L32 housekeeping gene expression.
Northern blot analysis
Total RNA (4mg per lane) was separated by electrophoresis through a
1M formaldehyde/1% agarose gel, blotted onto a nylon membrane
(Hybond-Nþ , Amersham Biosciences, Piscataway, NJ), UV cross-
linked, and then hybridized overnight at 651C to random primed,
[a-32P] cDNA probe for SFRP4 (from clone no. 1364770, ATCC) or
Wnt2 (gift from AP McMahon) or Fbn-1 (Kissin et al., 2002).
Prehybridization, hybridization, and washing of the filters were
carried out according to the protocol of Church and Gilbert. The
intensity of the signal was measured using a Phosphoimager
(Cyclone; Perkin-Elmer, Wellesley, MA).
Reverse transcription and real-time quantitative PCR
cDNA was synthesized by reverse transcription of 0.5–1mg of
purified total RNA, using random primers (Applied Biosystems,
Branchburg, NJ) and SuperScript II RNase H- Reverse Transcriptase
(Invitrogen Life Technologies). Real-time PCR was performed on an
ABI PRISM 7700 sequence Detector (Applied Biosystems) using
human SFRP4 (Hs00180066) and human 18S ribosomal RNA
(4319413E) TaqMan primers following the manufacturer’s protocol
(Applied Biosystems). PCR conditions were as follows: 501C for
2minutes (UNG cleavage) and 951C for 10minutes for one cycle,
and then 951C for 15 seconds and 601C for 1 second for 40 cycles.
Each reaction was carried out in duplicate and normalized to the
housekeeping internal control gene, 18S ribosomal RNA.
Western blot analysis
Skin samples were directly homogenized in Laemmli buffer contain-
ing 2% b-mercaptoethanol using a polytron homogenizer. Lysates
were incubated at 41C for 30minutes and centrifuged at 10,000 g
for 20minutes at 41C. MEFs were cultured in 0.1% serum containing
DMEM for 16 hours in the presence or absence of Wnt3a. Media
were collected and concentrated using centrifugal filters (Amicon
ultra-4 10k, Millipore, Billerica, MA). Total lysates and secreted
proteins were resolved on an SDS-PAGE gel, transferred to
polyvinylidine difluoride membranes (Immobilon-P; Millipore) using
standard methods, and then stained with Ponceau S. Membranes
were then blocked in 5% milk or 5% BSA 0.05% Tween- tris-
buffered saline for 1 hour, incubated overnight at 41C with
monoclonal mouse anti-SFRP4 antibody (Berndt et al., 2003),
polyclonal rabbit anti-Fbn-1 (Ab9543, gift from L. Sakai), anti-
bovine fibronectin (Calbiochem, San Diego, CA), anti-phospho
Smad3 (Rockland, Gilbertsville, PA), or anti-Smad2/3 (Upstate,
Billerica, MA) and then with a horseradish peroxidase-conjugated
goat anti-mouse IgG antibody (Sigma, St. Louis, MO) or donkey anti-
rabbit IgG (The Jackson Laboratory) for 1 hour. Signals were
developed using Supersignal West Pico chemiluminescent reagent
(Pierce, Rockford, IL) followed by autoradiography. Signal intensities
were quantified using NIH image 1.63 software and normalized to
total proteins.
Immunofluorescence
MEFs and human fibroblasts were grown in Lab-Tek eight-chamber
culture slides (Nalge Nunc International, Naperville, IL), fixed for
10minutes in 4% paraformaldehyde at room temperature, blocked
for 30minutes with 3% BSA-tris-buffered saline, and then incubated
for 2 hours with polyclonal rabbit antiserum directed against mouse
Fbn-1 (Ab9543, gift from L. Sakai), against MAGP-2 (gift from M.
Shipley), or against fibronectin (Calbiochem) in 3% BSA/tris-buffered
saline. Cells were then incubated for 1 hour with a rhodamine-
conjugated donkey anti-rabbit IgG (Jackson ImmnuoResearch, West
Grove, PA). Nuclei were counterstained by treating cells for
5minutes with 100 ngml1 Hoechst 33342 (Molecular Probes,
Eugene, OR). Specific fluorescence signals were visualized by an
Olympus BH-2 microscope under fluorescent light associated with
high-resolution Olympus DP70 camera and quantified using NIH
image 1.63 software.
Immunohistochemistry
Human skin biopsies from lesional areas of patients with SSc (n¼ 19)
and from healthy control subjects (n¼ 12) were fixed with 4%
paraformaldehyde, embedded in paraffin block, and mounted on
glass slides. Skin sections were subsequently deparaffinized,
dewaxed, and dehydrated through xylene and graded ethanol
washes. Tissues were then blocked for 30minutes with 3% BSA-
tris-buffered saline and incubated with rabbit polyclonal affinity-
purified anti-SFRP4 antibody (1:70 dilution; kindly provided by
Dr R. Friis) overnight at 41C. The slides were then rinsed in
tris-buffered saline and incubated for 30minutes at room temperature
with alkaline phosphatase-conjugated polymer directed against
mouse and rabbit Igs (Dako, Carpinteria, CA). Alkaline phosphatase
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activity was detected using Fast Red substrate (Envision,
DakoCytomation). Tissues were counterstained with Mayer’s
hematoxylin (Sigma). Three different blinded observers graded
SFRP4 staining in the papillary and deep reticular dermis using a
scale from 0 (no staining) to 4þ (maximal staining).
Statistical analysis
All data are presented as means7SD, and analyzed using unpaired
Student’s t-test or Mann–Whitney U-test. A P-value less than 0.05
was considered a significant difference.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
This work was supported by grants from the National Institutes of Health (RO1
AR051089-01) and the Scleroderma Foundation. We thank Dr A.P. McMahon
(Roche Research Center, Nutley, NJ) for providing us with the Wnt2 vector
and Dr R. Friis (University of Berne, Switzerland) for providing the polyclonal
rabbit anti-SFRP4 antibody.
REFERENCES
Abu-Jawdeh G, Comella N, Tomita Y, Brown LF, Tognazzi K, Sokol SY et al.
(1999) Differential expression of frpHE: a novel human stromal protein of
the secreted frizzled gene family, during the endometrial cycle and
malignancy. Lab Invest 79:439–47
Andl T, Reddy ST, Gaddapara T, Millar SE (2002) WNT signals are required
for the initiation of hair follicle development. Dev Cell 2:643–53
Berndt T, Craig TA, Bowe AE, Vassiliadis J, Reczek D, Finnegan R et al. (2003)
Secreted frizzled-related protein 4 is a potent tumor-derived phospha-
turic agent. J Clin Invest 112:785–94
Chang CH, Jiang TX, Lin CM, Burrus LW, Chuong CM, Widelitz R (2004)
Distinct Wnt members regulate the hierarchical morphogenesis of skin
regions (spinal tract) and individual feathers. Mech Dev 121:157–71
Chen Y, Shi-wen X, Eastwood M, Black CM, Denton CP, Leask A et al. (2006)
Contribution of activin receptor-like kinase 5 (transforming growth factor
beta receptor type I) signaling to the fibrotic phenotype of scleroderma
fibroblasts. Arthritis Rheum 54:1309–16
Cho TJ, Gerstenfeld LC, Einhorn TA (2002) Differential temporal expression of
members of the transforming growth factor beta superfamily during
murine fracture healing. J Bone Miner Res 17:513–20
Clevers H (2006) Wnt/beta-catenin signaling in development and disease.
Cell 127:469–80
Denton CP, Black CM, Abraham DJ (2006) Mechanisms and consequences
of fibrosis in systemic sclerosis. Nat Clin Pract Rheumatol 2:
134–144
Finch PW, He X, Kelley MJ, Uren A, Schaudies RP, Popescu NC et al. (1997)
Purification and molecular cloning of a secreted, Frizzled-related
antagonist of Wnt action. Proc Natl Acad Sci USA 94:6770–5
Fleischmajer R, Jacobs L, Schwartz E, Sakai LY (1991) Extracellular
microfibrils are increased in localized and systemic scleroderma skin.
Lab Invest 64:791–8
Fleischmajer R, Perlish JS, Duncan M (1983) Scleroderma. A model for
fibrosis. Arch Dermatol 119:957–62
Gardner H, Shearstone JR, Bandaru R, Crowell T, Lynes M, Trojanowska M
et al. (2006) Gene profiling of scleroderma skin reveals robust signatures
of disease that are imperfectly reflected in the transcript profiles of
explanted fibroblasts. Arthritis Rheum 54:1961–73
Gordon MD, Nusse R (2006) Wnt signaling: multiple pathways, multiple
receptors, and multiple transcription factors. J Biol Chem 281:22429–33
Green MC, Sweet HO, Bunker LE (1976) Tight-skin, a new mutation of the
mouse causing excessive growth of connective tissue and skeleton. Am J
Pathol 82:493–512
Hausler KD, Horwood NJ, Chuman Y, Fisher JL, Ellis J, Martin TJ et al. (2004)
Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast
formation. J Bone Miner Res 19:1873–81
Horvath LG, Henshall SM, Kench JG, Saunders DN, Lee CS, Golovsky D et al.
(2004) Membranous expression of secreted frizzled-related protein 4
predicts for good prognosis in localized prostate cancer and inhibits PC3
cellular proliferation in vitro. Clin Cancer Res 10:615–25
Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Grotendorst GR et al. (1995)
Significant correlation between connective tissue growth factor gene
expression and skin sclerosis in tissue sections from patients with
systemic sclerosis. J Invest Dermatol 105:280–4
James IE, Kumar S, Barnes MR, Gress CJ, Hand AT, Dodds RA et al. (2000)
FrzB-2: a human secreted frizzled-related protein with a potential role in
chondrocyte apoptosis. Osteoarthr Cartil 8:452–63
Jones SE, Jomary C (2002) Secreted Frizzled-related proteins: searching for
relationships and patterns. Bioessays 24:811–20
Kasturi KN, Shibata S, Muryoi T, Bona CA (1994) Tight-skin mouse an
experimental model for scleroderma. Int Rev Immunol 11:253–71
Kikuchi A, Kishida S, Yamamoto H (2006) Regulation of Wnt signaling by
protein-protein interaction and post-translational modifications. Exp Mol
Med 38:1–10
Kissin EY, Korn JH (2003) Fibrosis in scleroderma. Rheum Dis Clin North Am
29:351–69
Kissin EY, Lemaire R, Korn JH, Lafyatis R (2002) Transforming growth factor
beta induces fibroblast fibrillin-1 matrix formation. Arthritis Rheum
46:3000–9
Leask A, Holmes A, Abraham DJ (2002) Connective tissue growth factor:
a new and important player in the pathogenesis of fibrosis. Curr
Rheumatol Rep 4:136–42
Lee JL, Lin CT, Chueh LL, Chang CJ (2004) Autocrine/paracrine secreted
Frizzled-related protein 2 induces cellular resistance to apoptosis: a
possible mechanism of mammary tumorigenesis. J Biol Chem
279:14602–9
Leimeister C, Bach A, Gessler M (1998) Developmental expression patterns of
mouse sFRP genes encoding members of the secreted frizzled related
protein family. Mech Dev 75:29–42
Lemaire R, Bayle J, Lafyatis R (2006) Fibrillin in Marfan syndrome and tight
skin mice provides new insights into transforming growth factor-beta
regulation and systemic sclerosis. Curr Opin Rheumatol 18:582–7
Lemaire R, Bayle J, Mecham RP, Lafyatis R (2007) Microfibril-associated
MAGP-2 stimulates elastic fiber assembly. J Biol Chem 282:800–8
Lemaire R, Farina G, Kissin E, Shipley JM, Bona C, Korn JH et al. (2004a)
Mutant fibrillin 1 from tight skin mice increases extracellular matrix
incorporation of microfibril-associated glycoprotein 2 and type I
collagen. Arthritis Rheum 50:915–26
Lemaire R, Korn JH, Schiemann WP, Lafyatis R (2004b) Fibulin-2 and fibulin-
5 alterations in tsk mice associated with disorganized hypodermal elastic
fibers and skin tethering. J Invest Dermatol 123:1063–9
Lemaire R, Korn JH, Shipley JM, Lafyatis R (2005) Increased expression of
type I collagen induced by microfibril-associated glycoprotein 2: novel
mechanistic insights into the molecular basis of dermal fibrosis in
scleroderma. Arthritis Rheum 52:1812–23
Maretto S, Cordenonsi M, Dupont S, Braghetta P, Broccoli V, Hassan AB
et al. (2003) Mapping Wnt/beta-catenin signaling during mouse
development and in colorectal tumors. Proc Natl Acad Sci USA
100:3299–304
Melkonyan HS, Chang WC, Shapiro JP, Mahadevappa M, Fitzpatrick PA,
Kiefer MC et al. (1997) SARPs: a family of secreted apoptosis-related
proteins. Proc Natl Acad Sci USA 94:13636–41
Pablos JL, Everett ET, Norris JS (2004) The tight skin mouse: an animal model
of systemic sclerosis. Clin Exp Rheumatol 22:S81–5
Quondamatteo F, Reinhardt DP, Charbonneau NL, Pophal G, Sakai LY,
Herken R (2002) Fibrillin-1 and fibrillin-2 in human embryonic and early
fetal development. Matrix Biol 21:637–46
Rattner A, Hsieh JC, Smallwood PM, Gilbert DJ, Copeland NG, Jenkins NA
et al. (1997) A family of secreted proteins contains homology to the
880 Journal of Investigative Dermatology (2008), Volume 128
J Bayle et al.
Wnt Signaling in Skin Fibrosis
cysteine-rich ligand-binding domain of frizzled receptors. Proc Natl
Acad Sci USA 94:2859–63
Reddy S, Andl T, Bagasra A, Lu MM, Epstein DJ, Morrisey EE et al. (2001)
Characterization of Wnt gene expression in developing and postnatal
hair follicles and identification of Wnt5a as a target of Sonic hedgehog in
hair follicle morphogenesis. Mech Dev 107:69–82
Saito S, Kasturi K, Bona C (1999) Genetic and immunologic features
associated with scleroderma-like syndrome of TSK mice. Curr Rheumatol
Rep 1:34–7
Schumann H, Holtz J, Zerkowski HR, Hatzfeld M (2000) Expression of
secreted frizzled related proteins 3 and 4 in human ventricular
myocardium correlates with apoptosis related gene expression. Cardio-
vasc Res 45:720–8
Shi-wen X, Pennington D, Holmes A, Leask A, Bradham D, Beauchamp JR
et al. (2000) Autocrine overexpression of CTGF maintains fibrosis: RDA
analysis of fibrosis genes in systemic sclerosis. Exp Cell Res 259:213–24
Siracusa LD, McGrath R, Ma Q, Moskow JJ, Manne J, Christner PJ et al. (1996)
A tandem duplication within the fibrillin 1 gene is associated with the
mouse tight skin mutation. Genome Res 6:300–13
Surendran K, Schiavi S, Hruska KA (2005) Wnt-dependent beta-catenin
signaling is activated after unilateral ureteral obstruction, and recombi-
nant secreted frizzled-related protein 4 alters the progression of renal
fibrosis. J Am Soc Nephrol 16:2373–84
Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD et al.
(2004) Epigenetic inactivation of SFRP genes allows constitutive WNT
signaling in colorectal cancer. Nat Genet 36:417–22
Tebar M, Destree O, de Vree WJ, Ten Have-Opbroek AA (2001) Expression of
Tcf/Lef and sFrp and localization of beta-catenin in the developing
mouse lung. Mech Dev 109:437–40
Uren A, Reichsman F, Anest V, Taylor WG, Muraiso K, Bottaro DP et al.
(2000) Secreted frizzled-related protein-1 binds directly to Wingless and
is a biphasic modulator of Wnt signaling. J Biol Chem 275:4374–82
Varga J, Abraham D (2007) Systemic sclerosis: a prototypic multisystem
fibrotic disorder. J Clin Invest 117:557–67
Wallis DD, Tan FK, Kielty CM, Kimball MD, Arnett FC, Milewicz DM (2001)
Abnormalities in fibrillin 1-containing microfibrils in dermal fibroblast
cultures from patients with systemic sclerosis (scleroderma). Arthritis
Rheum 44:1855–64
Wang S, Krinks M, Lin K, Luyten FP, Moos M Jr (1997) Frzb, a secreted protein
expressed in the Spemann organizer, binds and inhibits Wnt-8. Cell
88:757–66
Whitfield ML, Finlay DR, Murray JI, Troyanskaya OG, Chi JT, Pergamens-
chikov A et al. (2003) Systemic and cell type-specific gene expression
patterns in scleroderma skin. Proc Natl Acad Sci USA 100:12319–24
Wolf V, Ke G, Dharmarajan AM, Bielke W, Artuso L, Saurer S et al. (1997)
DDC-4, an apoptosis-associated gene, is a secreted frizzled relative.
FEBS Lett 417:385–9
Yam JW, Chan KW, Ngan ES, Hsiao WL (2005) Genomic structure, alternative
splicing and tissue expression of rFrp/sFRP-4, the rat frizzled related
protein gene. Gene 357:55–62
York MR, Nagai T, Mangini AJ, Lemaire R, van Seventer JM, Lafyatis R (2007)
A macrophage marker, siglec-1, is increased on circulating monocytes in
patients with systemic sclerosis and induced by type i interferons and
toll-like receptor agonists. Arthritis Rheum 56:1010–20
Zhou X, Tan FK, Xiong M, Milewicz DM, Feghali CA, Fritzler MJ et al.
(2001) Systemic sclerosis (scleroderma): specific autoantigen genes are
selectively overexpressed in scleroderma fibroblasts. J Immunol 167:
7126–33
www.jidonline.org 881
J Bayle et al.
Wnt Signaling in Skin Fibrosis
